Heart Disease News and Research

Latest Heart Disease News and Research

Beige fat cells mediate subcutaneous fat's brain protection from dementia

Beige is considered a calming paint color, and scientists have new evidence that beige fat has a similar impact on the brain, bringing down the inflammation associated with the more common white fat and providing protection from dementia.

10 Aug 2021

Mount Sinai awarded more than $4 million to evaluate anal cancer screening in high-risk women

The Icahn School of Medicine at Mount Sinai has been awarded a grant of more than $4 million by the National Cancer Institute for a large-scale study to evaluate anal cancer screening in high-risk women who have been previously diagnosed with human papillomavirus (HPV) infection.

10 Aug 2021

Investigating the link between occupational noise exposure and cardiovascular disease

Occupational settings can involve exposure to loud noise, a known and preventable contributor to hearing loss.

10 Aug 2021

Pilot study assesses antibody response to third COVID-19 vaccine dose in kidney transplant recipients

A pilot study has begun to assess the antibody response to a third dose of an authorized COVID-19 mRNA vaccine in kidney transplant recipients who did not respond to two doses of the Moderna or Pfizer-BioNTech COVID-19 vaccine.

10 Aug 2021

Cardioprotective role of HIF1α in COVID-19 patients

The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which first emerged in Wuhan, China, in late December 2019, has quickly become the most urgent issue facing scientists worldwide. It has been reported that the respiratory infection causes cardiac dysfunction in 25-55% patients, including hospitalized patients and non-critical patients.

10 Aug 2021

Women underrepresented in cardiovascular clinical trials despite guidelines and legal requirements

Women remain underrepresented in cardiovascular clinical trials despite guidelines and legal requirements developed almost 30 years ago to ensure broader inclusivity, according to a report from the American College of Cardiology Cardiovascular Disease in Women Committee published today in the Journal of the American College of Cardiology.

9 Aug 2021

New study aims to determine the prevalence of COVID-related heart inflammation among elite athletes

An innovative study at Duke Health aims to determine the prevalence of COVID-related heart inflammation among top-level athletes and establish the symptoms and clinical features to ensure they receive timely and accurate diagnoses.

9 Aug 2021

Research finds disruption of flight-or-fight response in healthy young people diagnosed with COVID-19

New research published in The Journal of Physiology found that otherwise healthy young people diagnosed with COVID-19, regardless of their symptom severity, have problems with their nervous system when compared with healthy control subjects.

9 Aug 2021

Genetic testing in ambulatory cardiology clinics can benefit many patients

A person's genetics may hold the key to early intervention in cardiovascular disease, leading to better outcomes in patient care.

9 Aug 2021

New study shows how quickly vaping can affect the cells of healthy younger nonsmokers

The risk that both tobacco and electronic cigarettes can pose to regular smokers' health has been well documented, but a new UCLA study illustrates just how quickly vaping can affect the cells of even healthy younger nonsmokers.

9 Aug 2021

New technique can be used to directly image atherosclerotic plaques

If heart attacks blared a warning signal, patients would have a better chance of avoiding them. That's the idea behind a new imaging technique developed by a Spartan-led team of researchers.

9 Aug 2021

Study offers new insights on coronary microvascular dysfunction

New research has shown abnormalities in the tiny blood vessels of human hearts in regions well beyond the large arteries with atherosclerotic blockages that trigger the need for stents or bypass surgery.

9 Aug 2021

Quanterix Simoa® Technology Powers Breakthrough Alzheimer’s Disease Research Presented by Eli Lilly and Company at Alzheimer’s Association International Conference (AAIC) 2021

Ultra-sensitive Simoa® HD-X technology powers new findings that detect rapid reduction of plasma P-tau217 from donanemab, Lilly’s investigational antibody therapy for Alzheimer's disease at 12 weeks

From Quanterix 9 Aug 2021

Long COVID may be due to persistent immune disturbances

A new study discusses abnormalities in the immune response following COVID-19 in samples collected from patients who have recovered from COVID-19.

8 Aug 2021

Research reveals a microRNA network as putative mediators of myocardial reductive stress

Last year, University of Alabama at Birmingham researchers reported that reductive stress - an imbalance in the normal oxidation/reduction homeostasis - caused pathological changes associated with heart failure in a mouse model.

6 Aug 2021

FDA approves an intravenous medication to treat patients with Pompe disease

Today, the U.S. Food and Drug Administration approved Nexviazyme (avalglucosidase alfa-ngpt) for intravenous infusion to treat patients 1 year of age and older with late-onset Pompe disease.

6 Aug 2021

Review highlights barriers to recruiting women into cardiovascular trials and offers solutions

Women must be equally represented in heart disease research to ensure that treatment recommendations meet their specific health needs, according to a report published today in European Heart Journal, a journal of the European Society of Cardiology (ESC).

6 Aug 2021

Full dose anticoagulation with heparin improves outcomes for moderately ill COVID-19 patients

Collaborative international clinical trials testing full dose anticoagulation with heparin (a blood thinner) in both moderately ill and critically ill patients has found the treatment improves outcomes and reduces the need for vital organ support such as mechanical ventilation in moderately ill patients.

6 Aug 2021

Mobile interventional stroke team travels to patients for providing faster access to surgical treatment

Stroke patients were almost twice as likely to be functionally independent - mobile and able to perform daily tasks - at 90 days post-stroke if they were treated by a specialized mobile stroke team that traveled to them to perform mechanical clot removal, compared to those who were transferred to a thrombectomy stroke center, according to research conducted within the Mount Sinai Health System and published today in Stroke, a journal of the American Stroke Association, a division of the American Heart Association.

5 Aug 2021

Low glycemic diet results in important improvements for people with diabetes

For people with diabetes, sticking to a low glycemic diet results in small but important improvements in blood sugar levels, cholesterol, weight and other risk factors, finds a study published by The BMJ today.

5 Aug 2021

Heart Disease News and Research

Latest Heart Disease News and Research

Beige fat cells mediate subcutaneous fat's brain protection from dementia

Mount Sinai awarded more than $4 million to evaluate anal cancer screening in high-risk women

Investigating the link between occupational noise exposure and cardiovascular disease

Pilot study assesses antibody response to third COVID-19 vaccine dose in kidney transplant recipients

Cardioprotective role of HIF1α in COVID-19 patients

Women underrepresented in cardiovascular clinical trials despite guidelines and legal requirements

New study aims to determine the prevalence of COVID-related heart inflammation among elite athletes

Research finds disruption of flight-or-fight response in healthy young people diagnosed with COVID-19

Genetic testing in ambulatory cardiology clinics can benefit many patients

New study shows how quickly vaping can affect the cells of healthy younger nonsmokers

New technique can be used to directly image atherosclerotic plaques

Study offers new insights on coronary microvascular dysfunction

Quanterix Simoa® Technology Powers Breakthrough Alzheimer’s Disease Research Presented by Eli Lilly and Company at Alzheimer’s Association International Conference (AAIC) 2021

Long COVID may be due to persistent immune disturbances

Research reveals a microRNA network as putative mediators of myocardial reductive stress

FDA approves an intravenous medication to treat patients with Pompe disease

Review highlights barriers to recruiting women into cardiovascular trials and offers solutions

Full dose anticoagulation with heparin improves outcomes for moderately ill COVID-19 patients

Mobile interventional stroke team travels to patients for providing faster access to surgical treatment

Low glycemic diet results in important improvements for people with diabetes

Forensics and toxicology - Industry Focus eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Heart Disease News and Research

Latest Heart Disease News and Research

Forensics and toxicology - Industry Focus eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in